As mentioned by the colleagues Kitko et al, TNF-alpha cannot sufficiently be used as only biomarker for the prediction of the development of GVHD (96), but the combination with hsCRP and Kynurenine seems promising. The gene discussed is TNF; the disease is graft versus host disease.